The disease affects around 130,000 people in the US and another 115,000 in Europe. John Kraus, Otsuka's chief medical officer, said the results suggest sibeprenlimab could provide "a new ...

Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. The Japanese drugmaker said (PDF) “strategic reasons”—the pharma equivalent of “it’s not you, it’s me ...

SMBC Leasing & Finance.He has also served as Chief Representative of the Houston representative office spearheading SMBC’s Energy & Natural Resources business from 2006 to 2007.Mr. Otsuka holds a BA ...

Umio Otsuka, 63, a former Maritime Self Defense ... The last retired military officer appointed as chief priest, Nagayoshi Matsudaira, enshrined 14 prominent convicted war criminals alongside ...

Shares of Vera Therapeutics (NASDAQ:VERA) lost ~20% on Friday to reach a new 52-week low, in a move attributed to a potential market launch of a rival kidney disease therapy from Otsuka Holdings ...

Otsuka Medical Devices is also taking some rights ... v=Im2dzqevces&ab_channel=GrayMattersHealth GrayMatters' chief executive Oded Kraft said that Prism is "the first digital therapeutic device ...